Stealth-stage biotechnology company discovering and developing targeted therapies for serious and rare diseases by leveraging TGF-beta superfamily biology
Stealth-stage biotechnology company discovering and developing targeted therapies for serious and rare diseases by leveraging TGF-beta superfamily biology. The company focuses on antibody-based therapeutics and is at the discovery stage.